drugset / Trial / NCT02182518
Epinastine + Pseudoephedrine SR (Slow Release) Versus Epinastine Alone in Patients With Perennial Allergic Rhinitis
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of this trial is to evaluate the clinical efficacy and safety of Epinastine 10 mg + Pseudoephedrine 120 mg slow release (SR) administered twice a day, compared to Epinastine 10 mg alone administered twice daily.
Timeline
- Start
- 2000-05
- Primary completion
- 2001-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Epinastine | Small molecule | 10 mg | — |
| Subject | Pseudoephedrine | Small molecule | 120 mg | — |